Key result
Antihypertensive drugs, including RAS inhibitors and calcium channel blockers, may reverse cardiovascular hyperplasia by inducing therapeutic apoptosis independent of blood pressure reduction.
Why the study?
Do antihypertensive drugs induce therapeutic apoptosis to reverse cardiovascular hyperplasia in spontaneously hypertensive rats?
Do antihypertensive drugs induce therapeutic apoptosis to reverse cardiovascular hyperplasia in spontaneously hypertensive rats?
Antihypertensive therapies may reverse cardiovascular hyperplasia by inducing therapeutic apoptosis, an effect that appears independent of blood pressure reduction.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; hypothesis-generating for apoptosis-mediated effects in hypertensive animal models.
Cell growth and survival are potential therapeutic targets for the control of complications associated with hypertension. In most cardiovascular disorders, cardiac fibroblasts and large-vessel smooth muscle cells can replicate and thus contribute to the disease. We propose that cardiovascular hyperplasia may be reversed via therapeutic apoptosis induction with drugs that are safe and already used in the clinic. We first reported that, irrespective of the drug class, those drugs that are able to induce regression of cardiovascular hypertrophy are also able to reverse cardiovascular hyperplasia via apoptosis. Drugs active in this regard include inhibitors of the renin-angiotensin system, calcium channel blockers, and beta-blockers. Moreover, the effects of these drugs on cell survival is not merely secondary to blood pressure reduction. Therapeutic apoptosis in the cardiovascular system of the spontaneously hypertensive rat is characterized by a rapid and transient onset following initiation of antihypertensive treatment. Herein, the induction and termination of therapeutic apoptosis during drug treatment of hypertension will be briefly reviewed and supported by novel data suggesting that reversal of cardiovascular hyperplasia is associated with reduced cell growth and a resistance to further induction of therapeutic apoptosis, as shown in spontaneously hypertensive rats receiving an intermittent regime of nifedipine therapy. We propose that the presence of a cell subpopulation with defective cell cycle regulation may determine organ susceptibility to undergo therapeutic apoptosis.
No takes yet. Share an insight, caveat, or question.
deBlois et al. (2005) conducted a review in Hypertension and cardiovascular hyperplasia. Antihypertensive drugs (RAS inhibitors, calcium channel blockers, beta-blockers) was evaluated on Reversal of cardiovascular hyperplasia via apoptosis. Antihypertensive drugs, including RAS inhibitors and calcium channel blockers, may reverse cardiovascular hyperplasia by inducing therapeutic apoptosis independent of blood pressure reduction.
Synapse has enriched 10 related papers. Consider them for comparative context: